Jaundice or elevated bilirubin - Pennine GP Training



Jaundice or elevated bilirubin?

ALT and Alk phos

Albumin all normal?

Investigate according to GILBERT PROTOCOL

Patient ill or bilirubin > 200?

ADMIT ACUTELY or DISCUSS (*)

Bilirubin 100-200?

Phone or fax consultant gastro for urgent clinic visit (*)

Bilirubin 100

REFER

• Not ill

• Normal alk phos

• ALT < 100

• Not jaundiced

GP to investigate according to

TRANSAMINASE PROTOCOL

ABNORMAL LFT PROTOCOL (updated 2013)

(*) When referring jaundiced patients please provide a detailed drug history (including all prescriptions issued within the preceding three months) and also full results of all investigations performed. On this basis we can decide on urgency required. Most, but not all, jaundiced patients will be allocated to urgent appts.

GAMMA GT

GGT is a sensitive marker for hepatobiliary disease, but its use is limited by poor specificity.

Causes of raised GGT:

• Hepatobiliary disease (often with other liver enzyme abnormalities)

• Pancreatic disease

• Alcoholism

• Chronic obstructive pulmonary disease

• Renal failure

• Diabetes

• Myocardial infarction

• Drugs, e.g. carbamazepine, phenytoin and barbiturates and oral contraceptive pill

The use of GGT is in supporting a hepatobiliary source for other raised liver enzymes, e.g. ALP.

GILBERT PROTOCOL

Isolated hyperbilirubinaemia

This is usually Gilbert’s syndrome.

Check: LFTs, conjugated v unconjugated bilirubin, haemoglobin, reticulocyte count.

Criteria

Bilirubin fluctuates but 3x normal proceed to Step 2 & 3 invx and refer

If transaminases < 3x normal then …..

❖ Organise the following bloods & GP review:

➢ Weigh the patient and calculate BMI. (BMI>25 is abnormal and disease-associated.)

➢ Check BP

➢ Fasting chol:HDL & Trigs, Fasting Blood Sugar, FBC and Gamma GT

➢ GP Review 1 week later

If alcohol or fatty infiltration likely then support lifestyle changes and re-check after 3 months.

If not or if the lfts have not resolved after the 3 months of lifestyle changes then arrange the following investigations and consider referral:

STEP 3:

➢ Hep B and Hep C serology

➢ Autoantibodies including AMA, ASMA, ANF

➢ Coeliac screen

➢ Immunoglobulin levels

➢ Ferritin, Alpha-1-antitrypsin

➢ Caeruloplasmin if patient aged under 35y

➢ TFT

➢ INR

➢ If ALT persistently more than twice normal consider liver ultrasound. Note - not everyone needs an ultrasound!

FATTY LIVER DISEASE

Only consider the diagnosis if ….

HepB, HepC, ferritin, alpha-1-antitrypsin (and caeruloplasmin if age45 with NIDDM (as these patients are at higher risk of NASH and progression to cirrhosis).

Statins are safe to prescribe if the above criteria are satisfied and the patients are low risk for NASH

ALKALINE PHOSPHATASE PROTOCOL

Reference intervals contain 95% of the population, therefore 2.5% of the normal population have values above the upper reference limit. The combined analytical and biological variation for serum ALP is around 8%. For example, an ALP result of 125 U/L could be between 108 U/L and 143 U/L, spanning the upper reference limit. Minor increases in serum ALP levels are therefore more likely to be analytical, physiological, or statistical anomalies rather than indicating disease.

Elevations may be physiological or pathological

Common causes for raised ALP:

Physiological

• Third trimester of pregnancy

• Adolescents, due to bone growth

• Benign, familial

Pathological

• Bile duct obstruction

• Primary biliary cirrhosis

• Primary sclerosing cholangitis

• Drug induced cholestasis, e.g. anabolic steroids

• Metastatic liver disease

• Bone disease e.g Pagets

• Heart failure

Isolated raised alk phos with normal ALT and gamma GT

This suggests alk phos of bony origin. A careful medical and drug history and physical examination. Key features include abdominal pain or swelling, unintentional weight loss, back pain, bone pain, clinical indicators of liver disease, congestive cardiac failure, and end stage chronic kidney disease.

If patients are asymptomatic but have raised ALP levels of unknown cause, then the test for ALP should be repeated with Gamma GT, ALT, adj calcium, (PTH?) and Vit D levels, TFTs, Cr&Es, and FBC checked within four weeks if not part of the original profile. Don’t forget PSA in men, CXR in smoker, plasmaphoresis and ESR and breast exam if malignancy suspected. Also Paget’s Disease in the elderly.

Raised alk phos with abnormal ALT and gamma GT

1. If alk phos rasied check lfts & gamma gt. If abnormal then refer USS, and consider Antimitochondrial antibodies, Smooth Muscle Antibodies and Immunoglobulins.

2. If alk phos < 1.5 Upper Limit of Normal (ULN) re-check in 1 month. Values up to 20% over ULN are likely to be statistical rather than clinical 'abnormals'.

3. If < 1.2 x ULN recheck at 3 months and annually if stable

4. If on repeat > 1.2 x ULN then arrange alk phos isoenzymes (and if of bony origin consider PSA in men, CXR in smokers, breast exam in women, FBC & ESR +/- myeloma screen etc) but if not of bony origin consider transaminase bloods and discuss/refer.

5. If alkaline phosphatase >2 ULN (on a single measurement) then further investigation & probable referral is indicated.

Appendix

Drugs which causes abnormal LFTs

Common drug causes of raised alkaline phosphatase levels6 17

|Drugs |Mechanism |

|Antibiotics: | |

|Penicillin derivatives  |Intrahepatic cholestasis |

|Erythromycin  |Intrahepatic cholestasis |

|Aminoglycosides  |Enzyme induction |

|Antiepileptic drugs: | |

|Carbamazepine  |Intrahepatic cholestasis |

|Phenobarbital  |Enzyme induction |

|Phenytoin  |Enzyme induction |

|Antihistamines: | |

|Cetirizine  |Intrahepatic cholestasis |

|Cardiovascular drugs: | |

|Captopril  |Intrahepatic cholestasis |

|Diltiazem  |Enzyme induction |

|Felodipine  |Enzyme induction |

|Disease modifying agents: | |

|Penicillamine  |Intrahepatic cholestasis |

|Oral contraceptive pill (oestrogen)  |Enzyme induction |

|Steroids  |Enzyme induction |

|Psychotropic drugs: | |

|Monoamine oxidase inhibitors  |Intrahepatic cholestasis |

|Chlorpromazine  |Intrahepatic cholestasis |

Guideline d erived from the 2002 protocol by Dr G Sobala, Consultant Physician, Huddersfield Royal Infirmary. Updated using recent BMJ publications & GP notebook 2013.

Useful references

BMJ 2001;322:33-36 ABC of diseases of liver, pancreas, and biliary system

BMJ  2006;333:481-483 (2 September), doi:10.1136/bmj.333.7566.481 Cases in primary care laboratory medicine Biochemical "liver function tests"

Southern Derbyshire abnormal lfts guideline 2012

BMJ  2013;346:f976 interpretation an isolated raised alkaline phosphatase

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download